Search by Drug Name or NDC
NDC 13925-0522-01 Pentamidine Isethionate 300 mg/300mg Details
Pentamidine Isethionate 300 mg/300mg
Pentamidine Isethionate is a RESPIRATORY (INHALATION) INHALANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Seton Pharmaceuticals. The primary component is PENTAMIDINE ISETHIONATE.
MedlinePlus Drug Summary
Pentamidine is an anti-infective agent that helps to treat or prevent pneumonia caused by the organism Pneumocystis jiroveci (carinii). This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 13925-0522-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pentamidine Oral Inhalation
Product Information
NDC | 13925-0522 |
---|---|
Product ID | 13925-522_cfac4bb5-52dc-46ae-9a66-a47d745ed852 |
Associated GPIs | 16000045002170 |
GCN Sequence Number | 011791 |
GCN Sequence Number Description | pentamidine isethionate VIAL-NEB 300 MG INHALATION |
HIC3 | W4K |
HIC3 Description | ANTIPROTOZOAL DRUGS,MISCELLANEOUS |
GCN | 42980 |
HICL Sequence Number | 004162 |
HICL Sequence Number Description | PENTAMIDINE ISETHIONATE |
Brand/Generic | Generic |
Proprietary Name | Pentamidine Isethionate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Pentamidine Isethionate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INHALANT |
Route | RESPIRATORY (INHALATION) |
Active Ingredient Strength | 300 |
Active Ingredient Units | mg/300mg |
Substance Name | PENTAMIDINE ISETHIONATE |
Labeler Name | Seton Pharmaceuticals |
Pharmaceutical Class | Antiprotozoal [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206667 |
Listing Certified Through | 2024-12-31 |
Package
NDC 13925-0522-01 (13925052201)
NDC Package Code | 13925-522-01 |
---|---|
Billing NDC | 13925052201 |
Package | 1 VIAL in 1 CARTON (13925-522-01) / 300 mg in 1 VIAL |
Marketing Start Date | 2019-10-14 |
NDC Exclude Flag | N |
Pricing Information | N/A |